BGAM
BSX icon

Boussard & Gavaudan Asset Management’s Boston Scientific BSX Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,029
Closed -$269K – 11
2014
Q2 		$269K Buy
+21,029
New +$273K 0.13% 24
2014
Q1 		– Sell
-17,561
Closed -$211K – 114
2013
Q4 		$211K Buy
+17,561
New +$207K 0.15% 85

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Boussard & Gavaudan Asset Management's BSX Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 21,029 shares — an estimated $269K sold.

Boussard & Gavaudan Asset Management first reported a position in BSX in Q4 2013 and held it in 2 quarters. The position peaked at $269K in Q2 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 21,029 Boston Scientific shares in Q3 2014, an estimated $269K.
  • Boussard & Gavaudan Asset Management first reported a position in Boston Scientific in Q4 2013 and held it in 2 quarters.
  • Boussard & Gavaudan Asset Management's Boston Scientific position peaked at $269K in Q2 2014.
  • 437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.